Healthcare provider profile · identity verified

Steven B Taki, MD

Allopathic & Osteopathic Physicians|Family Medicine · TOPEKA, KS · NPI 1659805992

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Steven B Taki, MD received $126.08 in general payments during 2025 across 2 reported records.

Ascensia Diabetes Care Us Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$126.08

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Ascensia Diabetes Care Us Inc.	Unresolved — no canonical attribution shown	$126.08	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$126.08	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	624	176
Gabapentin	Gabapentin	388	86
Albuterol Sulfate Hfa	Albuterol Sulfate	366	108
Amlodipine Besylate	Amlodipine Besylate	334	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	324	62
Levothyroxine Sodium	Levothyroxine Sodium	314	76
Lisinopril	Lisinopril	302	78
Pantoprazole Sodium	Pantoprazole Sodium	296	82
Omeprazole	Omeprazole	272	66
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	241	61
Pregabalin	Pregabalin	204	42
Furosemide	Furosemide	171	53
Trazodone Hcl	Trazodone Hcl	169	42
Tamsulosin Hcl	Tamsulosin Hcl	168	46
Tramadol Hcl	Tramadol Hcl	165	27
Duloxetine Hcl	Duloxetine Hcl	160	26
Rosuvastatin Calcium	Rosuvastatin Calcium	158	51
Oxycodone Hcl	Oxycodone Hcl	155	27
Losartan Potassium	Losartan Potassium	148	46
Prednisone	Prednisone	135	79
Metformin Hcl Er	Metformin Hcl	131	33
Metformin Hcl	Metformin Hcl	130	34
Escitalopram Oxalate	Escitalopram Oxalate	127	37
Simvastatin	Simvastatin	125	34
Tizanidine Hcl	Tizanidine Hcl	123	31
Mounjaro	Tirzepatide	121	18
Montelukast Sodium	Montelukast Sodium	118	35
Hydrochlorothiazide	Hydrochlorothiazide	117	35
Meloxicam	Meloxicam	107	36
Zolpidem Tartrate	Zolpidem Tartrate	107	18
Fluticasone Propionate	Fluticasone Propionate	106	36
Eliquis	Apixaban	103	20
Celecoxib	Celecoxib	100	24
Potassium Chloride	Potassium Chloride	95	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	93	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	91	17
Alprazolam	Alprazolam	87	15
Sertraline Hcl	Sertraline Hcl	81	24
Jardiance	Empagliflozin	80	suppressed
Allopurinol	Allopurinol	79	20
Farxiga	Dapagliflozin Propanediol	78	19
Donepezil Hcl	Donepezil Hcl	75	20
Lorazepam	Lorazepam	75	15
Pravastatin Sodium	Pravastatin Sodium	74	20
Finasteride	Finasteride	73	22
Topiramate	Topiramate	73	19
Clopidogrel	Clopidogrel Bisulfate	68	22
Carvedilol	Carvedilol	67	24
Metoprolol Succinate	Metoprolol Succinate	67	18
Esomeprazole Magnesium	Esomeprazole Magnesium	66	12
Ozempic	Semaglutide	66	16
Clonazepam	Clonazepam	65	15
Metoprolol Tartrate	Metoprolol Tartrate	64	16
Buspirone Hcl	Buspirone Hcl	60	13
Famotidine	Famotidine	60	22
Venlafaxine Hcl Er	Venlafaxine Hcl	60	14
Amitriptyline Hcl	Amitriptyline Hcl	59	19
Naproxen	Naproxen	59	13
Quetiapine Fumarate	Quetiapine Fumarate	58	suppressed
Baclofen	Baclofen	57	17
Diclofenac Sodium	Diclofenac Sodium	57	25
Temazepam	Temazepam	57	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	57	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	17
Ondansetron Odt	Ondansetron	50	27
Spironolactone	Spironolactone	50	12
Levetiracetam	Levetiracetam	47	12
Paroxetine Hcl	Paroxetine Hcl	46	14
Torsemide	Torsemide	44	14
Hydroxyzine Hcl	Hydroxyzine Hcl	40	18
Alendronate Sodium	Alendronate Sodium	39	13
Aripiprazole	Aripiprazole	39	13
Ibuprofen	Ibuprofen	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	37	12
Cephalexin	Cephalexin	34	28
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Prazosin Hcl	Prazosin Hcl	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Terbinafine Hcl	Terbinafine Hcl	33	21
Azithromycin	Azithromycin	32	28
Citalopram Hbr	Citalopram Hydrobromide	32	11
Varenicline Tartrate	Varenicline Tartrate	32	12
Ezetimibe	Ezetimibe	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	12
Lovastatin	Lovastatin	30	suppressed
Diazepam	Diazepam	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Rizatriptan	Rizatriptan Benzoate	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	16
Levofloxacin	Levofloxacin	27	23
Trulicity	Dulaglutide	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Fluconazole	Fluconazole	26	18
Linzess	Linaclotide	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Eszopiclone	Eszopiclone	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Risperidone	Risperidone	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Valsartan	Valsartan	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Metronidazole	Metronidazole	18	13
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Lurasidone Hcl	Lurasidone Hcl	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	13
Loperamide	Loperamide Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Vraylar	Cariprazine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Lactulose	Lactulose	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Glipizide	Glipizide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$126.08 · 2 records	Ascensia Diabetes Care Us Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error